Key facts
- This page summarizes David W. Slack's Form 4 filing for LISATA THERAPEUTICS, INC. (LSTA).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Jan 2023, 15:10.
David W. Slack - 09 Jan 2023 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)
- Reporting relationship
- President & CBO, Director
- Issuer ticker
- LSTA
- Reported as of
- 09 Jan 2023
- Net transaction value
- -$10,074
- SEC form
- 4
- Accepted by SEC
- 11 Jan 2023, 15:10:05 UTC
- Prior SEC filing
- 16 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- James Nisco, Attorney-in-fact for David Slack
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David W. Slack filed Form 4 for LISATA THERAPEUTICS, INC. (LSTA) on 11 Jan 2023.
Change
- Previous filing in this sequence was filed on 16 Sep 2022.
- Current net transaction value: -$10,074.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LSTA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +24,000
- Change %
- Price
- $0.000000
- Shares after
- 24,000
- Date
- 09 Jan 2023
- Ownership
- Direct
- Footnotes
- F1, F2
LSTA
transaction
Common Stock
Tax liability
- Transaction value
- $10,074
- Shares
- -3,358
- Change %
- -14%
- Price
- $3.00
- Shares after
- 20,642
- Date
- 09 Jan 2023
- Ownership
- Direct
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LSTA
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +12,000
- Change %
- Price
- $0.000000
- Shares after
- 12,000
- Date
- 09 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,000
- Exercise price
- $3.00
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents 24,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
Footnote F2
Includes 18,000 unvested restricted stock.
Footnote F3
Shares withheld as payment of a tax liability on vesting of restricted stock.
Footnote F4
One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.